Clin Pharmacol Ther. 2022 Dec 19. doi: 10.1002/cpt.2831. Online ahead of print.
NO ABSTRACT
PMID:36534322 | DOI:10.1002/cpt.2831
Categories
Population Pharmacokinetic and Exposure-Response Analyses for Efficacy and Safety of Risankizumab in Subjects with Active Crohn’s Disease
